SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$16.64
Tradestie Score
42
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+78.6%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$122.27
|
$16.93B | 61.4 | 52 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$70.01
|
$15.70B | 45.4 | 36 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$259.28
|
$12.36B | 19.7 | 34 | Compare |
|
EXEL
Exelixis Inc
|
$70.70
|
$11.09B | 21.1 | 23 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.85
|
$10.76B | - | 42 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$248.69
|
$10.74B | - | 34 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.33
|
$10.53B | - | 56 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.33
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.54
|
$10.22B | - | 33 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$433.03
|
$10.01B | - | 56 | Compare |
More SMMT Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry